AiArthritis Voices 360 Talk Show
Education
This week join your host Tiffany Westrich-Robertson, CEO of International Foundation for AiArthritis, as she discusses the inherent desire of patients to make decisions with their doctors regarding treatment decisions without interference from insurance companies or governing agencies.
AiArthritis previously addressed this issue in the United States by leading the Ethics of Step Therapy investigation and concluded that while cost must be considered to ensure the “bucket” of healthcare funds are rationed appropriately, insurance companies justify choosing those low-cost treatments by citing research that has proven the drug is just as safe and effective as other options, proven usually through clinical trial research. But in our investigation, the patient experience was key to identifying the key to potentially putting treatment decisions back into the hands of their physicians.
Most patients with aiarthritis are “atypical” in that they would not meet the inclusion criteria required in the same clinical trials insurance companies use to cite to justify their cost-preferred treatment recommendations. Current trials only want patients who are “typical”, or fall under the label “general patient population”. Therefore, when a patient is not “typical”, the responsibility to determine the safest and most efficacious treatment should fall on their doctor, who is ethically obligated to treat patients based on their individual characteristics.
AiArthritis is building on these findings by teaming with FORWARD Databank (formerly known as the National Data Bank for Rheumatic Diseases) to conduct post-market research into patient subgroups to show potential differences in treatment response based on individual characteristics. AiArthritis also works on this issue as an Advisory Task Force Member for Let My Doctors Decide, a group led by American Autoimmune Related Diseases Association (AARDA).
Whether it is insurance companies in the United States or other non-medical groups deciding treatment use in other countries, the issue is the same. Patients want to work with their doctors to decide which treatment is best for them. If you believe this and would like to share your experiences or support on this issue, please send us an email or message us on social media.
Patient Voices and All Other Stakeholders - Join our AiArthritis Voices Program and Connect to Opportunities to Have Your Voice Counted!
If you are a patient, a parent of a juvenile patient, or any other stakeholder (doctor, nurse, researcher, industry representative, or other health services person) - are you ready to join the conversation? It's your turn to pull up a seat. Join our new AiArthritis Voices program, where people living with AiArthritis diseases and other stakeholders who we need 'at the table' to solve problems that impact education, advocacy, and research sign up to have a voice in our initiatives. By signing up, you’ll get notified of opportunities to be more involved with this show - including submitting post-episode comments and gaining insider information on future show topics. Patients and all other stakeholders are encouraged to join so we can match you with opportunities to pull up a seat and TOGETHER - as equals - solve the problems of today and tomorrow.
JOIN TODAY!
AiArthritis Voices 360 is produced by the International Foundation for Autoimmune and Autoinflammatory Arthritis. Visit us on the web at www.aiarthritis.org/talkshow. Find us on Twitter, Instagram, TikTok, or Facebook (@ifAiArthritis) or email us (podcast@aiarthritis.org).
Be sure to check out our top-rated show on Feedspot!
Episode 96 - Social Wellness with an AiArthritis disease
Episode 95 - Volunteering with AiArthritis
Episode 94 Rheumy Rounds Rewind: Improving Doctor and Patient Communication During Office Visits
Episode 93: Reproductive Health and AiArthritis Diseases
#360it: Medicare Drug Price Negotiation: How Will it Affect Patient Access?
Episode 92 Breaking Research: Pharma & Non-Pharma 2023
Episode 91: AiArthritis Voices 360 REWIND - Distinction Between Autoimmune and Autoinflammatory diseases
Episode 90: Why Won’t They Diagnose Me?
Episode 89: Surgery with an AiArthritis Disease
Episode 88 Biosimilars - Interchangeability & Switching 2023
Episode 87: AiArthritis Rant Discussions - Inspired by Am I the @$$hole
Episode 86 : Organ Involvement: Disease Symptom or Comorbidity?
Episode 85: Elevator Pitches to Explain AiArthritis Diseases
Ep 84: I’m a Mystery Patient, Now What?
Episode 83: Improving Communication Throughout the JIA Journey
Episode 82: AUTO + Autoinflammatory Arthritis: Diagnosis, Please!
Episode 81 RheumyRounds: The Good, The Bad & The Ugly Pt. 2- Improving Office Visit Communication
Episode 80 RheumyRounds: The Good, the Bad and the Ugly - Improving Office Communication
Episode 79 : Patient Leadership In Research
Ep 78 Diversity Equity Inclusion and Access
Create your
podcast in
minutes
It is Free
The No-Frills Teacher Podcast
Heal, Survive & Thrive!
Summarize | رادیو سامرایز
The Jordan B. Peterson Podcast
The Mel Robbins Podcast